Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997-2013.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 26870829)

Published in EBioMedicine on December 17, 2015

Authors

Michael G Head1, Joseph R Fitchett2, Vaitehi Nageshwaran3, Nina Kumari3, Andrew Hayward4, Rifat Atun5

Author Affiliations

1: University College London, Farr Institute for Health Informatics, 222 Euston Road, London NW1 2DA, United Kingdom; Academic Unit of Clinical and Experimental Sciences Faculty of Medicine, University of Southampton, United Kingdom. Electronic address: m.head@ucl.ac.uk.
2: London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom; Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA, USA.
3: Imperial College London, School of Medicine, London, United Kingdom.
4: University College London, Farr Institute for Health Informatics, 222 Euston Road, London NW1 2DA, United Kingdom.
5: Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA, USA.

Articles cited by this

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 26.76

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 14.88

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

UK investments in global infectious disease research 1997-2010: a case study. Lancet Infect Dis (2012) 5.42

A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst (2010) 3.14

NIH disease funding levels and burden of disease. PLoS One (2011) 2.56

Market failure and the poverty of new drugs in maternal health. PLoS Med (2008) 1.70

Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. J Antimicrob Chemother (2013) 1.34

Rational allocation of Australia's research dollars: does the distribution of NHMRC funding by National Health Priority Area reflect actual disease burden? Med J Aust (2009) 1.12

Systematic analysis of funding awarded for norovirus research to institutions in the United Kingdom, 1997-2010. J R Soc Med (2013) 1.10

Funding infectious disease research: a systematic analysis of UK research investments by funders 1997-2010. PLoS One (2014) 1.05

Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK funding. BMJ Open (2014) 1.05

Pricing infectious disease. The economic and health implications of infectious diseases. EMBO Rep (2008) 1.04

Are the Norwegian health research investments in line with the disease burden? Health Res Policy Syst (2014) 0.98

Infectious disease research investments follow colonial ties: questionable ethics. Int Health (2014) 0.97

Progress toward global eradication of dracunculiasis--January 2013-June 2014. MMWR Morb Mortal Wkly Rep (2014) 0.93

Funding healthcare-associated infection research: a systematic analysis of UK research investments, 1997-2010. J Hosp Infect (2014) 0.91

Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013. EBioMedicine (2015) 0.89

Burden of illness estimates for priority setting: a debate revisited. Health Policy (1998) 0.89

Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom, 1997-2010. J Viral Hepat (2014) 0.84

Systematic analysis of funding awarded to institutions in the United Kingdom for infectious disease research, 1997-2010. JRSM Open (2015) 0.84

Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997-2010. BMJ Open (2014) 0.83

It's time for alltrials registered and reported. Cochrane Database Syst Rev (2013) 0.83

Investments in sexually transmitted infection research, 1997-2013: a systematic analysis of funding awarded to UK institutions. J Glob Health (2015) 0.78

Infectious disease research investments: systematic analysis of immunology and vaccine research funding in the UK. Vaccine (2013) 0.78

Investing in sepsis research: systematic analysis of UK public and philanthropic funding 1997-2010. JRSM Open (2014) 0.78